Join the EHE Foundation for a conversation about genomic profiling — an important tool that can help guide treatment decisions, support and inform clinical trials, and pave a path to progress in EHE research. Dr. James L. Chen, a medical oncologist specializing in the diagnosis and treatment of sarcomas at The Ohio State University James Cancer Center and Senior Vice President for Medical Informatics at Tempus AI, will explain genomic profiling – also called next generation sequencing, why it matters for people with EHE, and how it informs clinical care and drug development.
TISSUE DONATION IS CRITICAL TO FIND TREATMENTS! Click here to learn more.
